Trial Profile
A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine ER [extended-release] in children and adolescent outpatients with social anxiety disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jan 2008
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- Sponsors Wyeth
- 15 Nov 2007 Results have been published
- 16 Mar 2007 New trial record.